Ototoxic side-effects of the IKs-channel blocker HMR1556

Hearing Research

Volumn 172, Issue 1-2, 2002, Pages 145-150

  Hartmann, Rainer ^a   Gerlach, Uwe ^b   Klinke, Rainer ^a  

^a Physiologisches Institut III   (Germany)

^b SANOFI AVENTIS DEUTSCHLAND GMBH   (Germany)

Author keywords

Blood labyrinth barrier; Cochlear action potential; Hearing loss; Ototoxicity; Potassium channel; Stria vascularis

Indexed keywords

ANTIARRHYTHMIC AGENT; N [3 HYDROXY 2,2 DIMETHYL 6 (4,4,4 TRIFLUOROBUTOXY)CHROMAN 4 YL] N METHYLMETHANESULFONAMIDE; N [3 HYDROXY 2,2 DIMETHYL 6 (4,4,4 TRIFLUOROBUTOXY)CHROMAN 4 YL] N METHYLMETHANESULFONIDE; POTASSIUM CHANNEL BLOCKING AGENT; UNCLASSIFIED DRUG;

ACTION POTENTIAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUDITORY THRESHOLD; CAT; COCHLEA; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ELECTROCARDIOGRAM; HEARING; HEARING IMPAIRMENT; HEART RATE; NONHUMAN; OTOTOXICITY; PRIORITY JOURNAL;

ACTION POTENTIALS; ANIMALS; AUDITORY THRESHOLD; CATS; CHROMANS; COCHLEA; EVOKED POTENTIALS, AUDITORY; HEART; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; POTASSIUM CHANNELS, VOLTAGE-GATED; SULFONAMIDES;

EID: 0036805665     PISSN: 03785955     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5955(02)00576-2     Document Type: Article

References (21)

1. Evans E.F., Klinke R. The effects of intracochlear and systemic Furosemide on the poperties of single cochlear nerve fibres in the cat. J. Physiol. 331:1982;409-427.
2. Galley N., Klinke R., Pause M., Storch W.H. The effect of flaxedil (gallamine triethiodide) on the efferent endings in the cochlea. Pflügers Arch. Ges. Physiol. 330:1971;1-4.
3. Ks-channel blockers: potential antiarrhythmic agents. Drugs Future. 26:2001;473-484.
4. Gogelein H., Bruggemann A., Gerlach U., Brendel J., Busch A.E. Inhibition of Iks channels by HMR 1556. Naunyn-Schmiedeberg's Arch. Pharmacol. 362:2000;480-488.
5. Gottl K.H., Roesch A., Klinke R. Quantitative evaluation of ototoxic side effects of furosemide, piretanide, bumetanide, azosemide and ozolinone in the cat. A new approach to the problem of ototoxicity. Naunyn-Schmiedeberg's Arch. Pharmacol. 331:1985;275-282.
6. Herbert D.A., Mitchell R.A. Blood gas tensions and acid-base balance in awake cats. J. Appl. Physiol. 30:1971;434-436.
7. Juhn S.K., Rybak L.P. Labyrinthine barriers and cochlear homeostasis. Acta Otolaryngol. (Stockholm). 91:1981;529-534.
8. Klinke R., Mertens M. Quantitaive assessment of Torasemide ototoxicity. Arzneim.forsch. Drug Res. 38:1988;136-153.
9. Klinke, R., Gottl, K.H., Roesch, A., 1981. Testing strategy for ototoxic side-effects. In: Klinke, R., Lahn, W., Querfurth, H., Scholtholt, J. (Eds.), Ototoxic Side Effects of Diuretics. Scand. Audiol. Suppl. 14, pp. 95-109.
10. Ks/KvLQT1 channel via protein kinase C in vestibular dark cells. Am. J. Physiol. 273:1997;C2022-C2029.
11. + channel in apical membrane of strial marginal cells. Hear. Res. 115:1998;82-92.
12. Mori N.M., Sakagami K., Fukazawa K., Matsunaga T. An immunohistochemical and electrophysiological study on Isk protein in the stria vascularis of the guinea pig. Eur. Arch. Oto-Rhino-Laryngol. 250:1993;186-189.
13. Muller M., Smolders J.W.T., Ding-Pfennigdorff D., Klinke R. Regeneration after tall hair cell damage following severe acoustic trauma in adult pigeons: Correlation between cochlear morphology, compound action potential responses and single fibre properties in single animals. Hear. Res. 102:1996;133-154.
14. Sakagami M., Fukazawa K., Matsunaga T., Fujita H., Mori N., Takumi T., Ohkubo H., Nakanishi S. Cellular localization of rat Isk protein in the stria vascularis by immunohistochemical observation. Hear. Res. 56:1991;168-172.
15. Ks by (R)-2-(2,4-Trifluoromethyl)-N-[2-oxo-5-phenyl-1-(2,2,2-trifluoroethyl)-2,3- dihydro-1H-benzol[e][1,4]diazepin-3-yl]acetamide. J. Med. Chem. 40:1997;3865-3868.
16. + secretion through an Isk channel in apical membrane of vestibular dark cell epithelium of gerbil. J. Membr. Biol. 146:1995;283-291.
17. Vetter D.E., Wangemann P., McLaughlin K.J., Marcus D.C., Heinemann S.F., Barhanin J. Innen ear defects induced by null mutation of the isk gene. Neuron. 17:1996;1251-1264.
18. Wangemann P. Comparison of ion transport mechanisms between vestibular dark cells and strial marginal cells. Hear. Res. 90:1995;149-157.
19. Wangemann, P., 2000. Der cochleäre kaliumionenhaushalt. Z. Audiol. Suppl. III, 7-10.
20. + secretion and activates apical Isk channel in vestibular dark cells. J. Membr. 147:1995;263-273.
21. Ks) has no effect on cochlear structure and function in vivo. Pharmacol. Toxicol. 88:2001;45-50.